News

According to an announcement made on February 15, 2022, McGill University researchers adopted the Canadian Light Source (CLS) at the University of Saskatchewan to create a unique approach for manufacturing synthetic bone tissue. The discovery comes after more than 30...

Novo Nordisk announced the expansion of its existing research collaboration in oral drug delivery technologies with the Massachusetts Institute of Technology (MIT) and Brigham and Women’s Hospital (BWH). Since 2015, scientists from Novo Nordisk and the laboratories of Prof. Giovanni...

The European Commission (EC) has granted marketing authorisation to Boehringer Ingelheim and Eli Lilly and Company’s Jardiance (empagliflozin) to treat symptomatic chronic heart failure in adult patients. With the latest development, Jardiance became the first treatment to be approved for...

Midatech Pharma PLC, a drug delivery technology company, announced an extension of its existing R&D collaboration with Janssen Pharmaceutica NV (Janssen) originally announced on 21 July 2020. On 17 June 2021 the company announced that, using its Q-Sphera technology, it...

Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced a cooperative agreement with the Biomedical Advanced Research and Development Authority (BARDA), part of the Department of Health and Human Services (HHS) Office of the Assistant Secretary...

Alcami, a U.S.-based pharmaceutical contract development and manufacturing organization (CDMO), announced the addition of a 3,800 ft² Non-GMP Formulation Development Laboratory (FDL). The dedicated Non-GMP formulation development space, which is co-located within the same facility as Alcami's parenteral manufacturing...

Moderna chose Kenya as its location for a $500 million African mRNA vaccine manufacturing effort. The pharmaceutical company says it signed a letter of understanding with Kenyan officials to develop a cutting-edge mRNA plant, that was first announced in...